Early assessment with 18F-2-fluoro-2-deoxyglucose positron emission tomography/computed tomography to predict short-term outcome in clear cell renal carcinoma treated with nivolumab.
Tadashi TabeiNoboru NakaigawaTomohiro KanetaIchiro IkedaKeiichi KondoKazuhide MakiyamaHisashi HasumiNarihiko HayashiTakashi KawaharaKoji IzumiKimito OsakaKentaro MuraokaJun-Ichi TeranishiYasuhide MiyoshiYasushi YumuraHiroji UemuraKazuki KobayashiTomio InoueMasahiro YaoPublished in: BMC cancer (2019)
Registered in University Hospital Medical Information Network in JAPAN [ UMIN0000008141 ], registration date: 11 Jun 2012.